Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Quoin Pharmaceuticals Ltd.

NASDAQ: QNRX · Life Sciences · 7 alerts · CIK 1671502

Share price
$3.56Close, Nov 16
Market cap
$250M
Shares outstanding
70.29MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Quoin Pharmaceuticals Ltd. filings on SEC EDGAR ↗

5:26 PM ET 8-K
Capital Raise

Quoin Pharmaceuticals Capital Raise

Quoin Pharmaceuticals entered into an at-the-market (ATM) sales agreement with Leerink Partners LLC to sell American Depositary Shares (ADSs) from time to time. Leerink Partners will act as the sales agent and receive a 3.0% commission on gross proceeds from any sales made under the program.

Counterparty
Leerink Partners LLC
6:35 AM ET 8-K
Clinical Trial Data

Quoin Pharmaceuticals Clinical Trial Data

Quoin Pharmaceuticals announced the publication of a peer-reviewed case report detailing 21 months of compassionate use treatment with QRX003 in a pediatric Netherton Syndrome patient, showing an improvement from severe to clear skin. The company also reaffirmed that its ongoing Phase 2/3 study of QRX003 expects to complete recruitment by the end of 2026 with topline data anticipated in Q2 2027.

Term
21 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.